75 related articles for article (PubMed ID: 9542474)
1. Passive versus electrotransport-facilitated transdermal absorption of ketorolac.
Park K; Verotta D; Gupta SK; Sheiner LB
Clin Pharmacol Ther; 1998 Mar; 63(3):303-15. PubMed ID: 9542474
[TBL] [Abstract][Full Text] [Related]
2. Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children.
Kauffman RE; Lieh-Lai MW; Uy HG; Aravind MK
Clin Pharmacol Ther; 1999 Apr; 65(4):382-8. PubMed ID: 10223774
[TBL] [Abstract][Full Text] [Related]
3. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
Gordon MS; Chowhan Z
Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
[TBL] [Abstract][Full Text] [Related]
4. Nasal formulations of ketorolac tromethamine: technological evaluation--bioavailability and tolerability in rabbits.
Santus G; Rivolta R; Bottoni G; Testa B; Canali S; Peano S
Farmaco; 1993 Dec; 48(12):1709-23. PubMed ID: 8135994
[TBL] [Abstract][Full Text] [Related]
5. Enantiomeric disposition of ketorolac in goats following administration of a single intravenous and oral dose.
Nagilla R; Deshmukh DD; Copedge KJ; Miller S; Martin B; Bell EC; Duran SH; Ravis WR
J Vet Pharmacol Ther; 2009 Feb; 32(1):49-55. PubMed ID: 19161455
[TBL] [Abstract][Full Text] [Related]
6. Absorption of transdermally delivered ketorolac acid in humans.
Roy SD; Manoukian E; Combs D
J Pharm Sci; 1995 Jan; 84(1):49-52. PubMed ID: 7714743
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of ketorolac enantiomers following intramuscular administration of the racemate.
Hayball PJ; Wrobel J; Tamblyn JG; Nation RL
Br J Clin Pharmacol; 1994 Jan; 37(1):75-8. PubMed ID: 8148223
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective analysis of ketorolac in human plasma by high-performance liquid chromatography.
Hayball PJ; Tamblyn JG; Holden Y; Wrobel J
Chirality; 1993; 5(1):31-5. PubMed ID: 8448075
[TBL] [Abstract][Full Text] [Related]
9. Ketorolac tromethamine transdermal gel: development, in vitro and in vivo evaluation.
Dubey R; Bommagani M; Venkateswarlu V; Mullangi R; Karnati HR; Thammera RK; Menon VC
J Pain Palliat Care Pharmacother; 2009; 23(1):26-34. PubMed ID: 19296352
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat.
Jett MF; Ramesha CS; Brown CD; Chiu S; Emmett C; Voronin T; Sun T; O'Yang C; Hunter JC; Eglen RM; Johnson RM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1288-97. PubMed ID: 10027870
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic study of 4'-acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole)acetate in the rat.
Sabater J; Domenéch J; Obach R
Arzneimittelforschung; 1993 Feb; 43(2):154-9. PubMed ID: 8457238
[TBL] [Abstract][Full Text] [Related]
12. Dermatopharmacokinetics of salicylate following topical injection in rats: effect of osmotic pressure and injection volume on salicylate disposition.
Yoshida D; Todo H; Hasegawa T; Sugibayashi K
Int J Pharm; 2007 Jun; 337(1-2):142-7. PubMed ID: 17280809
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and safety of ketorolac following single intranasal and intramuscular administration in healthy volunteers.
McAleer SD; Majid O; Venables E; Polack T; Sheikh MS
J Clin Pharmacol; 2007 Jan; 47(1):13-8. PubMed ID: 17192497
[TBL] [Abstract][Full Text] [Related]
14. Stereospecific pharmacokinetics and toxicodynamics of ketorolac after oral administration of the racemate and optically pure enantiomers to the rat.
Jamali F; Lovlin R; Corrigan BW; Davies NM; Aberg G
Chirality; 1999; 11(3):201-5. PubMed ID: 10079499
[TBL] [Abstract][Full Text] [Related]
15. Permeability of pure enantiomers of ketorolac through human cadaver skin.
Roy SD; Chatterjee DJ; Manoukian E; Divor A
J Pharm Sci; 1995 Aug; 84(8):987-90. PubMed ID: 7500285
[TBL] [Abstract][Full Text] [Related]
16. A double-blind study comparing two single-dose regimens of ketorolac with diclofenac in pain due to cancer.
Minotti V; Betti M; Ciccarese G; Fumi G; Tonato M; Del Favero A
Pharmacotherapy; 1998; 18(3):504-8. PubMed ID: 9620101
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective pharmacokinetics of ketorolac in calves after a single intravenous and oral dose.
Nagilla R; Deshmukh DD; Duran SH; Ravis WR
J Vet Pharmacol Ther; 2007 Oct; 30(5):437-42. PubMed ID: 17803736
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of skin permeation and accumulation profiles of ketorolac fatty esters.
Bhandari KH; Newa M; Yoon SI; Kim JS; Kim DD; Kim JA; Yoo BK; Woo JS; Lyoo WS; Choi JY; Lim HT; Lee JH; Choi HG; Yong CS
J Pharm Pharm Sci; 2007; 10(3):278-87. PubMed ID: 17727791
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.
Flach AJ; Dolan BJ; Donahue ME; Faktorovich EG; Gonzalez GA
Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery.
Stewart R; Grosserode R; Cheetham JK; Rosenthal A
Clin Ther; 1999 Apr; 21(4):723-32. PubMed ID: 10363737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
